Therapeutic TriMix / mRNA based Vaccine in Chronic HIV-1 Infected Patients Receiving Antiretroviral Therapy

Project Information

IHIVARNA

Grant agreement ID: 602570

Project closed

Start date 1 December 2013

End date 30 November 2017

Funded under

• Specific Programme "Cooperation": Health

Total cost € 7 826 907,20

EU contribution € 5 984 720,00

Coordinated by

CONSORCI INSTITUT D'INVESTIGACIONS BIOMEDIQUES AUGUST PI I SUNYER
Spain